ptis Therapeutics (COEP)
Search documents
ptis Therapeutics (COEP) - 2023 Q1 - Quarterly Report
2023-05-14 16:00
For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from _____________ to _____________ Table of Contents x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 COEPW Nasdaq Global Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 COEPTIS THERAPEUTICS HOLDINGS, INC. Delaware 98-1465952 (State or other jurisdiction of incorporation or org ...
ptis Therapeutics (COEP) - 2022 Q4 - Annual Report
2023-03-28 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number: 001-39669 Coeptis Therapeutics Holdings, Inc. (Exact name of registrant as specified in its charter) Delawar ...
ptis Therapeutics (COEP) - 2022 Q3 - Quarterly Report
2022-11-17 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number. 001-39669 COEPTIS THERAPEUTICS HOLDINGS, INC. (Exact name of registrant as specified in its charter) | --- | --- | |----------- ...
ptis Therapeutics (COEP) - 2022 Q2 - Quarterly Report
2022-08-08 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number. 001-39669 BULL HORN HOLDINGS CORP. (Exact name of registrant as specified in its charter) British Virgin Islands 98-1465952 (State o ...
ptis Therapeutics (COEP) - 2022 Q1 - Quarterly Report
2022-05-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39669 BULL HORN HOLDINGS CORP. (Exact name of registrant as specified in its charter) | --- | --- | --- | --- | --- | --- | |-------|- ...
ptis Therapeutics (COEP) - 2021 Q4 - Annual Report
2022-04-07 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39669 BULL HORN HOLDINGS CORP. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------------------- ...
ptis Therapeutics (COEP) - 2021 Q2 - Quarterly Report
2021-09-13 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39669 BULL HORN HOLDINGS CORP. (Exact name of registrant as specified in its charter) British Virgin Islands 98-1465952 (State or other ...
ptis Therapeutics (COEP) - 2021 Q1 - Quarterly Report
2021-07-29 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one Ordinary Share and one Redeemable Warrant BHSEU The Nasdaq Stock Market LLC Ordinary Shares, par value $0.0001 per share BHSE The Nasdaq Stock Market LLC Warrants, each whole warrant exercisable for onehalf of one Ordinary Share for $11.50 per whole share BHSEW The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT ...
ptis Therapeutics (COEP) - 2020 Q4 - Annual Report
2021-03-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39669 BULL HORN HOLDINGS CORP. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------------------- ...
ptis Therapeutics (COEP) - 2020 Q3 - Quarterly Report
2020-12-10 01:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 British Virgin Islands 98-1465952 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one Ordinary Share and one Redeemable Warrant BHSEU The Nasdaq Stock Market LLC Ordinary Shares BHSE The Nasdaq Stock Market LLC Warrants, each whole warrant exercisable for one-half of one Ordinary S ...